Natera, INC Form 4 insider transactions
NASDAQ
NTRA
Natera, INCNatera co-founder Jonathan Sheena sold a total of 7,200 shares of common stock on December 18, 2024, through pre-arranged 10b5-1 trading plans.
NASDAQ
NTRA
Natera, INCNatera's Executive Chairman, Matthew Rabinowitz, sold a significant number of shares on December 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCA Natera Inc. executive sold 1,767 shares of common stock at a weighted average price of $170.2367 per share.
NASDAQ
NTRA
Natera, INCA Natera executive exercised stock options and sold shares to cover tax obligations, with sales prices ranging from $166.5937 to $166.5938 per share.
NASDAQ
NTRA
Natera, INCNatera's Executive Chairman, Matthew Rabinowitz, exercised stock options and reported changes in his beneficial ownership of the company's stock.
NASDAQ
NTRA
Natera, INCDirector Roelof Botha sold a total of 87,473 shares of Natera, Inc. common stock through estate planning vehicles on December 2, 2024.
NASDAQ
NTRA
Natera, INCNatera's Executive Chairman, Matthew Rabinowitz, sold a portion of his shares through a pre-arranged 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCA Natera director, Gail Boxer Marcus, sold a total of 9,682 common stock shares in multiple transactions on November 19, 2024.
NASDAQ
NTRA
Natera, INCDirector Roy D. Baynes of Natera, Inc. exercised stock options and sold shares on November 15, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCNatera CEO Steven Chapman sold a total of 4,728 shares of common stock on November 15, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCNatera co-founder Jonathan Sheena sold a significant number of shares on November 13, 2024, under pre-arranged 10b5-1 trading plans.
NASDAQ
NTRA
Natera, INCA Natera director, Gail Boxer Marcus, sold a total of 2,212 shares of common stock in multiple transactions on November 14, 2024.
NASDAQ
NTRA
Natera, INCNatera's Executive Chairman, Matthew Rabinowitz, exercised stock options, increasing his direct holdings of common stock.
NASDAQ
NTRA
Natera, INCNatera co-founder Jonathan Sheena sold a total of 7,300 shares of common stock on November 8, 2024, through a pre-arranged 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCMichael Brophy, CFO of Natera, Inc., sold 1,866 shares of common stock at a price of $126.45 per share on October 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCDaniel Rabinowitz, SEC. and Chief Legal Officer of Natera, Inc., reported the sale of 1,057 shares of common stock to cover tax obligations related to vesting RSUs.
NASDAQ
NTRA
Natera, INCSolomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,196 shares of common stock to cover tax obligations related to vesting RSUs.
NASDAQ
NTRA
Natera, INCJohn Fesko, President and Chief Business Officer of Natera, Inc., sold 929 shares of common stock to cover tax obligations related to vesting RSUs.
NASDAQ
NTRA
Natera, INCNatera CEO Steven Chapman sold 3,960 shares of common stock on October 28, 2024, to satisfy tax withholding obligations related to vesting RSUs.
NASDAQ
NTRA
Natera, INCMichael Brophy, CFO of Natera, Inc., sold shares of common stock to cover tax obligations related to vesting RSUs and under a pre-arranged 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCDirector Herm Rosenman acquired 178 shares of Natera, Inc. common stock through the issuance of fully vested Restricted Stock Units (RSUs) in lieu of quarterly retainer fees.
NASDAQ
NTRA
Natera, INCDirector James Healy received 153 fully vested Restricted Stock Units (RSUs) from Natera in lieu of quarterly retainer fees.
NASDAQ
NTRA
Natera, INCDirector Roelof Botha reports acquisition of Natera, Inc. stock through restricted stock units (RSUs) in lieu of quarterly retainer fees.
NASDAQ
NTRA
Natera, INCDirector Roy D. Baynes acquired 124 shares of Natera, Inc. common stock through the issuance of fully vested Restricted Stock Units (RSUs) in lieu of quarterly retainer fees.
NASDAQ
NTRA
Natera, INCNatera's CFO, Michael Brophy, executed sales of common stock on October 24 and 25, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
NTRA
Natera, INCSolomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold shares of common stock to satisfy tax withholding obligations related to vesting RSUs.
NASDAQ
NTRA
Natera, INCNatera's President and Chief Business Officer, John Fesko, sold shares of common stock on October 21 and 22, 2024, to satisfy tax withholding obligations related to vesting RSUs.
NASDAQ
NTRA
Natera, INCMichael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NASDAQ
NTRA
Natera, INCJonathan Sheena, co-founder of Natera, Inc., reports transactions involving restricted stock units and common stock.
NASDAQ
NTRA
Natera, INCDaniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., reports transactions involving common stock and restricted stock units, including acquisitions and sales to cover tax obligations.